With the live broadcast of this operation, and the good recovery of the patient after surgery, coupled with media reports, Sun Feng's 'occipital muscle flap cerebellar surface application' soon made neurosurgeons and brain surgeons all over the world known!

After all, although it belongs to the category of neurosurgery, the surgical path actually belongs to the category of neurosurgeons. Therefore, many brain doctors are also very interested in paying attention to this new type of surgery that opens up a new treatment method for penguin disease patients in the world!

"Ruan Bin, you really created the world's first new surgery this time! I really can't believe that you can create it casually. Qiao Yejian patted his ass.

"It's not casual, I've studied penguin disease before, but now I'm just accidentally taking out my not very mature treatment. After all, this occipital flap cerebellar surface application still can't completely cure this penguin disease!" Ruan Bin smiled.

"Although it cannot be completely cured, it can greatly alleviate the patient's condition, and can allow the patient to recover some functions after surgery, such as walking, talking, and self-care in daily life, I think it is already very good. ”

"That's right, I think this surgery is very worth promoting and making it benefit more penguin patients!"

A Chinese neurosurgeon is touted one after another.

......

Far away in Huaxia, Jingcheng University Hospital.

Brain.

Consultation room.

In addition to a few brain masters from Jingcheng University Hospital, there are seven or eight brain brains from other hospitals.

If someone finds that this group of brain scientists are gathered together for a meeting, it is estimated that many brain doctors will be surprised!

Because, among this group of people, they are all among the top brain scientists in China!

In particular, Wang Guozheng, who is an academician of the Department of Brain Sciences, is a leading figure in brain surgery in China.

The group of bigwigs came together to discuss the surgical consultation about the use of rapamycin intracranial drug balloons for the treatment of intracranial atherosclerotic stenosis.

Interventional treatment of intracranial stenosis suffered a Waterloo in 2013, and the publication of the SAMMPRIS study once disoriented the field of treatment.

Interventional treatment of intracranial stenosis is also known as cerebral infarction treatment. Cerebral infarction is also known as stroke and stroke. Stroke is a condition in which brain tissue is damaged due to bleeding or blockage of cerebral blood vessels, preventing blood from flowing into the brain. Ischemic stroke accounts for about 80% of cases, and intracranialatheroscleroticstenosis (ICAS) is one of the important causes of ischemic stroke, with significant differences among different ethnic groups, with intracranial atherosclerotic stroke accounting for 30% to 50% of patients in Asian populations.

The results of the 2014 study of symptomatic intracranial aortic stenosis and occlusion in China showed that the incidence of intracranial atherosclerosis in patients with ischemic stroke or transientischemic attack (TIA) in China was 46.6%, and patients with ICAS had more severe symptoms, longer hospital stays, and higher stroke recurrence rates, and the recurrence rate increased with the increase of stenosis.

Due to the waterloo of the interventional treatment of intracranial stenosis in 2013, a group of brain experts and neurosurgeons in China began a new round of research on this intracranial treatment.

After years of research, Wang Guozheng and others have developed a new treatment method, that is, drug balloon therapy! It has ignited a glimmer of light in the treatment in this field.

They have been doing animal experiments for a long time!

It proved to work very well!

The use of rapamycin drug balloons can effectively reduce stent implantation and reduce the recurrence rate of stenosis, thereby reducing the financial burden on patients and reducing medical insurance. If successful, it will be one of the most advanced vascular treatment technologies in the world.

Now, they are discussing who should do this surgery and who will do the world's first rapamycin intracranial drug balloon for the treatment of intracranial atherosclerotic stenosis!

Their volunteer patient this time, a 52-year-old man, was admitted to the hospital for "motor aphasia" six months ago.

Based on medical history, physical examination, and ancillary examinations, the diagnosis was "cerebral infarction, left middle cerebral artery occlusion"

The patient had severe stenosis at the beginning of the left middle cerebral artery, which was about 90% stenosis, and it was found that such severe stenosis made surgery very difficult.

Traditional intracranial interventions are simply not successful.

In this case, this patient is most suitable for surgery with a highly skilled rapamycin drug balloon catheter!

If this operation is successful, then it proves that their rapamycin drug balloon catheter surgery has indeed achieved something that traditional surgery could not do before!

It also proves that this new type of drug surgery of theirs has epoch-making effects and therapeutic significance!

"It is well known that intracranial artery stenosis is one of the important causes of ischemic stroke, especially in Asian populations. However, the treatment of intracranial artery stenosis is still being explored, and there is no standard treatment standard. It is hoped that the emergence of intracranial drug-coated balloons can provide a new and effective treatment option for intracranial arterial stenosis and provide a direction for our future exploration. So this first operation is very critical and important, and the whole world is watching us!" Wang Guozheng said solemnly.

"But now the patient's intracranial blood vessels are complex, and some of the intracranial blood vessels are already in danger and can rupture at any time. The most important thing is that intracranial blood pressure is high...... The risk factor and difficulty factor of our operation are very high! We need a surgeon with very precise operation to complete it!" Zhou Jiayu sighed. He is an expert in vascular surgery and he knows how difficult this operation can be!

The patient has severe stenosis at the beginning of the left middle cerebral artery, which is about 90% stenosis, and the purpose of surgery is to transport the rapamycin drug balloon through the blood vessel to the lesion and then place it.

In this way, stent implantation can be effectively reduced, and the recurrence rate of stenosis can be reduced!

It's easy to say, but it's not easy to get the cyst safely to the lesion.

Didn't you see the patient's severe stenosis at the beginning of the left middle cerebral artery, about 90% stenosis?

In other words, you need to find a path in the 10% non-narrow vascular network that can lead to the place of the cyst at the lesion!

"Which of you would like to fight?" Wang Guozheng asked in front of everyone.

A bunch of old guys were silent.

The youngest of the people here are 45 years old.

Although they are all big names, they are not very sure in their hearts now, so no one wants to joke with the lives of volunteers!

"Why don't we ask for help?" suggested one expert.

"Foreign aid, do any of you know the master of this field?" asked Zhou Jiayu's eyes lit up.

"Well, people who are better than me seem to be here......"

"I don't know the sharp-edged swordsman either. ”